Psychedelic Therapeutics Insurance

Companies utilizing psychedelic compounds like psilocybin, MDMA, ketamine and LSD are pushing the boundaries of therapeutic innovation. Relm provides comprehensive coverage for businesses operating in the psychedelics industry, from manufacturing and research to distribution and therapy. Our coverage helps manage and mitigate the impact of risk exposure in this dynamic space, supporting growth in psychedelic therapeutics and ensuring the protection of your assets and reputation.

Contact Us Contact Us Products Products

Psychedelic therapeutics insurance research

Psychedelic Therapeutics Coverage Built for Innovators

Psychedelic Therapeutics Risks

01

Regulatory Compliance

As the psychedelic therapeutics industry is subject to stringent regulations, businesses must navigate a complex legal landscape. Companies involved in psychedelic therapy must stay aligned with federal and state regulations, such as those governing clinical trials, patient confidentiality, and substance classification. We offer insurance that helps ensure compliance with evolving laws, mitigating the risk of penalties and legal challenges.
02

Product Liability

The development and distribution of psychedelic compounds come with inherent product liability concerns. Issues such as contamination during manufacturing, incorrect dosing, or adverse reactions can lead to costly legal battles. Our coverage protects businesses against such claims, providing peace of mind for manufacturers and distributors.
03

Therapeutic Use Liability

As psychedelic compounds gain acceptance in therapeutic settings, the risk of patient harm — whether from improper administration or unforeseen side effects — becomes more pronounced. There are risks associated with patient safety and potential adverse reactions. Psychedelic therapy insurance policies can offer protection against claims related to therapeutic treatment, helping businesses minimize financial vulnerabilities.

Latest News & Insights

Scroll

View All View All